| Validation of the Arabic version of the “self-evaluation of negative symptoms” scale (SNS) A Hajj, S Hallit, K Chamoun, H Sacre, S Obeid, C Haddad, S Dollfus, ... BMC psychiatry 20 (1), 240, 2020 | 19 | 2020 |
| Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): A retrospective cohort study of presentations with acute toxicity to European … ML Waters, PI Dargan, C Yates, AM Dines, F Eyer, I Giraudon, ... Clinical Toxicology 62 (6), 378-384, 2024 | 14 | 2024 |
| Mechanisms of neurorespiratory toxicity induced by fentanyl analogs—lessons from animal studies K Chamoun, L Chevillard, A Hajj, J Callebert, B Mégarbane Pharmaceuticals 16 (3), 382, 2023 | 9 | 2023 |
| Negative symptoms in schizophrenia: correlation with clinical and genetic factors A Hajj, S Hallit, K Chamoun, H Sacre, S Obeid, C Haddad, S Dollfus, ... Pharmacogenomics 22 (7), 389-399, 2021 | 7 | 2021 |
| Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders K Chamoun, J Mouawad, P Salameh, H Sacre, R Haddad, LR Khabbaz, ... BMC psychiatry 23 (1), 797, 2023 | 6 | 2023 |
| Changes in clinical features and severity in patients presenting to European emergency departments with acute cannabis toxicity over the 10‐year period from 2013 to 2022 Ò Miró, M Galicia, PI Dargan, DM Wood, AM Dines, F Heyerdahl, ... Addiction, 2025 | | 2025 |
| Investigating Sex Differences in Opioid Use Disorder Risk Factors: Insights from Cross-Section Lebanese Study Population K Chamoun, P Salameh, H Sacre, J Mouawad, L Rabbaa, B Megarbane, ... European Psychiatry 67 (S1), S115-S115, 2024 | | 2024 |
| The pattern of neurorespiratory effects induced by the synthetic opioid U-47700 significantly differ from that related to morphine in the rat K Chamoun, L Chevillard, A Hajj, J Callebert, B Megarbane CLINICAL TOXICOLOGY 62, 24-24, 2024 | | 2024 |
| The neurorespiratory effects induced by fentanyl and carfentanil in comparison to morphine in the rat K Chamoun, L Chevillard, A Hajj, J Callebert, B Megarbane CLINICAL TOXICOLOGY 62, 24-25, 2024 | | 2024 |
| Alcohol and Sedative Use Disorders in the Lebanese Population: Role of Sleep and Psychiatric Factors K Chamoun, N Wehbe, P Salameh, H Sacre, M Atallah, J Mouawad, ... European Psychiatry 67 (S1), S131-S132, 2024 | | 2024 |
| Opioid Use Disorder in Three Samples of the Lebanese Population: Correlation with Clinical and Genetic Factors K Chamoun, FHM Lteif, P Salameh, H Sacre, R Haddad, L Rabbaa, ... European Psychiatry 67 (S1), S99-S99, 2024 | | 2024 |
| Des facteurs de risque aux effets neurorespiratoires: une exploration préclinique, clinique et pharmacogénétique du trouble de l'usage des opioïdes K Chamoun Université Paris Cité; Université Saint-Joseph (Beyrouth), 2023 | | 2023 |
